Tecentriq Atezolizumab Injection For Intravenous Use 1200 MG Trademark Details

This mark is alive with a status of Non-Final Action - Mailed. The last case file activity for this mark occured 8 years ago on Tuesday, March 29, 2016, according to the United State Patent & Trademark Office
Word Mark Tecentriq Atezolizumab Injection for Intravenous Use 1200 Mg
Status Alive 641 — Non-Final Action - Mailed

Current Owner

Genentech, Inc. of South San Francisco, CA

View all trademarks for Genentech, Inc.
Other Trademarks for Genentech, Inc.
Serial Number 86850524
Status Date Tuesday, March 29, 2016
Filing Date Tuesday, March 29, 2016

Correspondent

GENENTECH, INC.
1 DNA WAY
SOUTH SAN FRANCISCO, CA 94080-4990

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Description of Mark The mark consists of THE WORD TECENTRIQ WITH ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG UNDER IT. THE FIRST T IN TECENTRIQ HAS THREE ARROWS POINTING INWARDS IN A CIRCLE ABOVE IT IN THE UPPER LEFT HAND CORNER.
Goods & Services Pharmaceutical oncology preparations

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, December 22, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.